Kulkarni Samarth
Insider CIK 1682019 · CRSP Please See Remarks, Director · BDTX Director · RPTX Director · CNTA Director · ORKA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-10-26 | 2026-10-28 | 28,750 | — | $0 | 28,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-10-26 | 2026-10-28 | 57,500 | — | $0 | 57,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-10-19 | 2026-10-20 | 47,837 | $49.78 | $2.38M | 311,899 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-10-16 | 2026-10-20 | 100,000 | — | — | 200,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-10-16 | 2026-10-20 | 100,000 | — | — | 359,736 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-10-14 | 2026-10-15 | 4,098 | $49.26 | $201.9K | 259,736 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-10-13 | 2026-10-15 | 8,333 | — | — | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-10-13 | 2026-10-15 | 8,333 | — | — | 263,834 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2026-06-26 | 2026-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 48,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 208,474 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 48,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 48,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 40,000 | — | $0 | 0 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-06-02 | 2026-06-03 | 9,136 | — | $0 | 9,136 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-23 | 2026-03-24 | 10,020 | $46.78 | $468.7K | 255,501 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 114,249 | — | $0 | 114,249 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 81,875 | — | $0 | 81,875 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-20 | 2026-03-24 | 19,687 | — | $0 | 39,375 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-20 | 2026-03-24 | 19,687 | — | $0 | 265,521 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-16 | 2026-03-17 | 10,349 | $48.26 | $499.4K | 245,834 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-14 | 2026-03-17 | 20,625 | — | $0 | 61,875 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-14 | 2026-03-17 | 20,625 | — | $0 | 256,183 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-11 | 2026-03-12 | 9,798 | $52.80 | $517.3K | 235,558 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-10 | 2026-03-12 | 19,250 | — | $0 | 19,250 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-10 | 2026-03-12 | 19,250 | — | $0 | 245,356 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-02-19 | 2026-02-20 | 6,967 | $52.58 | $366.3K | 226,106 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-02-18 | 2026-02-20 | 13,250 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-02-18 | 2026-02-20 | 13,250 | — | $0 | 233,073 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-22 | 2026-01-22 | 60,000 | $60.23 | $3.61M | 134,201 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-20 | 2026-01-22 | 8,567 | $52.10 | $446.3K | 194,201 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-20 | 2026-01-22 | 21,433 | $51.61 | $1.11M | 202,768 | SEC↗ |
| CRSP CRISPR Therapeutics AG | G Gift | 2025-12-18 | 2025-12-22 | 30,000 | — | $0 | 224,201 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-10-17 | 2025-10-20 | 50,895 | $67.91 | $3.46M | 254,201 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-10-16 | 2025-10-20 | 100,000 | — | $0 | 300,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-10-16 | 2025-10-20 | 100,000 | — | $0 | 305,096 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-10-14 | 2025-10-15 | 4,242 | $66.60 | $282.5K | 205,096 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-10-13 | 2025-10-15 | 8,334 | — | $0 | 8,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-10-13 | 2025-10-15 | 8,334 | — | $0 | 209,338 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-10-03 | 2025-10-03 | 49,500 | — | $0 | 49,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | G Gift | 2025-09-17 | 2025-09-19 | 6,000 | — | $0 | 201,004 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-08-18 | 2025-08-19 | 13,081 | $58.15 | $760.7K | 207,004 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-08-16 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-08-16 | 2025-08-19 | 25,000 | — | $0 | 220,085 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-06-20 | 2025-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2025-06-12 | 2025-06-12 | 30,550 | — | $0 | 30,550 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2025-06-02 | 2025-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-03-21 | 2025-03-24 | 10,031 | $41.23 | $413.6K | 195,085 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-03-20 | 2025-03-24 | 19,688 | — | $0 | 59,062 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-03-20 | 2025-03-24 | 19,688 | — | $0 | 205,116 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 82,500 | — | $0 | 82,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-03-12 | 2025-03-12 | 4,462 | $43.32 | $193.3K | 185,428 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-03-11 | 2025-03-12 | 9,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-03-11 | 2025-03-12 | 9,973 | $42.42 | $423.1K | 180,890 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-03-11 | 2025-03-12 | 9,000 | — | $0 | 189,890 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-03-10 | 2025-03-12 | 19,250 | — | $0 | 38,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-03-10 | 2025-03-12 | 19,250 | — | $0 | 190,863 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-02-19 | 2025-02-19 | 6,928 | $52.80 | $365.8K | 189,973 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-02-19 | 2025-02-21 | 18,360 | $55.21 | $1.01M | 171,613 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-02-18 | 2025-02-19 | 13,250 | — | $0 | 13,250 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-02-18 | 2025-02-19 | 13,250 | — | $0 | 208,541 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-02-18 | 2025-02-19 | 11,640 | $55.05 | $640.8K | 196,901 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-12-24 | 2024-12-27 | 13,751 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-12-24 | 2024-12-27 | 13,751 | $16.21 | $222.9K | 195,291 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-12-02 | 2024-12-04 | 15,000 | $55.10 | $826.5K | 181,540 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-11-11 | 2024-11-13 | 6,879 | $56.27 | $387.1K | 196,540 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-11-11 | 2024-11-13 | 23,121 | $55.43 | $1.28M | 203,419 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-10-16 | 2024-10-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-10-16 | 2024-10-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-10-14 | 2024-10-15 | 4,293 | $46.28 | $198.7K | 226,540 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-10-13 | 2024-10-15 | 8,333 | — | $0 | 16,667 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-10-13 | 2024-10-15 | 8,333 | — | $0 | 230,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | G Gift | 2024-08-08 | 2024-08-12 | 100,000 | — | $0 | 222,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-06-25 | 2024-06-27 | 48,000 | — | $0 | 48,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2024-06-17 | 2024-06-20 | 27,200 | — | $0 | 27,200 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2024-06-06 | 2024-06-06 | 30,550 | — | $0 | 30,550 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-04-15 | 2024-04-17 | 19,582 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-04-15 | 2024-04-17 | 19,582 | $19.12 | $374.4K | 227,704 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-04-15 | 2024-04-17 | 18,378 | $59.88 | $1.10M | 209,326 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-04-15 | 2024-04-17 | 1,204 | $60.40 | $72.7K | 208,122 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-03-20 | 2024-03-22 | 78,750 | — | $0 | 78,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-03-20 | 2024-03-22 | 105,000 | — | $0 | 105,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-03-15 | 2024-03-18 | 20,000 | — | $0 | 19,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-03-15 | 2024-03-18 | 20,000 | $19.12 | $382.4K | 228,122 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-03-15 | 2024-03-18 | 9,387 | $73.06 | $685.8K | 208,122 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-03-15 | 2024-03-18 | 10,613 | $71.97 | $763.8K | 217,509 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-03-12 | 2024-03-12 | 4,583 | $74.44 | $341.2K | 208,122 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-03-11 | 2024-03-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-03-11 | 2024-03-12 | 9,000 | — | $0 | 212,705 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-03-11 | 2024-03-12 | 9,802 | $78.26 | $767.1K | 203,705 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-03-10 | 2024-03-12 | 19,250 | — | $0 | 57,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-03-10 | 2024-03-12 | 19,250 | — | $0 | 213,507 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-02-20 | 2024-02-21 | 6,370 | $79.67 | $507.5K | 194,257 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-02-18 | 2024-02-21 | 13,250 | — | $0 | 26,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-02-18 | 2024-02-21 | 13,250 | — | $0 | 200,627 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-02-15 | 2024-02-16 | 20,000 | — | $0 | 39,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-02-15 | 2024-02-16 | 12,949 | $79.94 | $1.04M | 194,428 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-02-15 | 2024-02-16 | 20,000 | $19.12 | $382.4K | 207,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-02-15 | 2024-02-16 | 5,951 | $81.04 | $482.3K | 188,477 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-02-15 | 2024-02-16 | 1,100 | $81.66 | $89.8K | 187,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-01-29 | 2024-01-31 | 50,000 | — | $0 | 100,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-01-29 | 2024-01-31 | 50,000 | $19.12 | $956.0K | 237,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-01-29 | 2024-01-31 | 49,300 | $60.50 | $2.98M | 188,077 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-01-29 | 2024-01-31 | 700 | $61.10 | $42.8K | 187,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-01-16 | 2024-01-18 | 20,000 | — | $0 | 59,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-01-16 | 2024-01-18 | 20,000 | $19.12 | $382.4K | 207,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-01-16 | 2024-01-18 | 20,000 | $62.50 | $1.25M | 187,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-10-13 | 2023-10-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-10-13 | 2023-10-17 | 52,500 | — | $0 | 52,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-06-22 | 2023-06-23 | 48,000 | — | $0 | 48,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 27,200 | — | $0 | 27,200 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-05-30 | 2023-06-01 | 25,000 | — | $0 | 79,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-05-30 | 2023-06-01 | 5,999 | $64.46 | $386.7K | 399,077 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-05-30 | 2023-06-01 | 2,400 | $66.83 | $160.4K | 387,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-05-30 | 2023-06-01 | 25,000 | $19.12 | $478.0K | 412,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-05-30 | 2023-06-01 | 9,300 | $65.63 | $610.4K | 389,777 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-05-30 | 2023-06-01 | 7,301 | $63.61 | $464.4K | 405,076 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2023-05-16 | 2023-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-04-25 | 2023-04-27 | 25,000 | — | $0 | 104,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-04-25 | 2023-04-27 | 4,393 | $51.45 | $226.0K | 387,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-04-25 | 2023-04-27 | 20,607 | $50.50 | $1.04M | 391,770 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-04-25 | 2023-04-27 | 25,000 | $19.12 | $478.0K | 412,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-03-29 | 2023-03-31 | 25,000 | — | $0 | 129,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-03-29 | 2023-03-31 | 19,719 | $44.37 | $874.9K | 392,658 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-03-29 | 2023-03-31 | 5,281 | $44.78 | $236.5K | 387,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-03-29 | 2023-03-31 | 25,000 | $19.12 | $478.0K | 412,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2023-03-13 | 2023-03-14 | 5,358 | $43.22 | $231.6K | 382,463 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2023-03-13 | 2023-03-14 | 4,086 | $43.22 | $176.6K | 387,377 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-03-11 | 2023-03-14 | 9,000 | — | $0 | 18,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-03-11 | 2023-03-14 | 9,000 | — | $0 | 391,463 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-03-10 | 2023-03-14 | 11,833 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-03-10 | 2023-03-14 | 77,000 | — | $0 | 77,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-03-10 | 2023-03-14 | 188,000 | — | $0 | 188,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-03-10 | 2023-03-14 | 11,833 | — | $0 | 387,821 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-02-27 | 2023-03-01 | 25,000 | — | $0 | 154,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-02-27 | 2023-03-01 | 1,100 | $49.20 | $54.1K | 375,988 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-02-27 | 2023-03-01 | 10,180 | $47.71 | $485.7K | 390,808 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-02-27 | 2023-03-01 | 13,720 | $48.57 | $666.4K | 377,088 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-02-27 | 2023-03-01 | 25,000 | $19.12 | $478.0K | 400,988 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2023-02-21 | 2023-02-22 | 6,373 | $48.26 | $307.6K | 375,988 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-02-18 | 2023-02-22 | 13,250 | — | $0 | 39,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-02-18 | 2023-02-22 | 13,250 | — | $0 | 382,361 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-01-27 | 2023-01-31 | 25,000 | — | $0 | 179,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-01-27 | 2023-01-31 | 25,000 | $19.12 | $478.0K | 394,111 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-01-27 | 2023-01-31 | 1,800 | $50.60 | $91.1K | 392,311 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2023-01-27 | 2023-01-31 | 23,200 | $51.54 | $1.20M | 369,111 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-12-28 | 2022-12-30 | 25,000 | — | $0 | 204,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-12-28 | 2022-12-30 | 4,634 | $41.45 | $192.1K | 369,111 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-12-28 | 2022-12-30 | 20,366 | $40.81 | $831.1K | 373,745 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-12-28 | 2022-12-30 | 25,000 | $19.12 | $478.0K | 394,111 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-12-06 | 2022-12-08 | 58,233 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-12-06 | 2022-12-08 | 58,233 | $1.81 | $105.4K | 369,111 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-12-05 | 2022-12-06 | 19,401 | $52.26 | $1.01M | 310,878 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-12-03 | 2022-12-06 | 40,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-12-03 | 2022-12-06 | 40,000 | — | $0 | 330,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-11-28 | 2022-11-30 | 25,000 | — | $0 | 229,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-11-28 | 2022-11-30 | 5,572 | $54.85 | $305.6K | 292,589 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-11-28 | 2022-11-30 | 2,310 | $55.40 | $128.0K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-11-28 | 2022-11-30 | 17,118 | $53.58 | $917.2K | 298,161 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-11-28 | 2022-11-30 | 25,000 | $19.12 | $478.0K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-10-26 | 2022-10-28 | 5,418 | — | $0 | 254,582 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-10-26 | 2022-10-28 | 19,582 | — | $0 | 13,751 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-10-26 | 2022-10-28 | 7,188 | $55.69 | $400.3K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-10-26 | 2022-10-28 | 11,312 | $54.97 | $621.8K | 297,467 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-10-26 | 2022-10-28 | 5,418 | $19.12 | $103.6K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-10-26 | 2022-10-28 | 19,582 | $16.21 | $317.4K | 309,861 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-10-26 | 2022-10-28 | 4,000 | $54.06 | $216.2K | 308,779 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-10-26 | 2022-10-28 | 2,500 | $52.73 | $131.8K | 312,779 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-09-28 | 2022-09-30 | 25,000 | — | $0 | 33,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-09-28 | 2022-09-30 | 23,200 | $64.58 | $1.50M | 292,079 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-09-28 | 2022-09-30 | 1,800 | $64.97 | $116.9K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-09-28 | 2022-09-30 | 25,000 | $16.21 | $405.3K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-08-29 | 2022-08-31 | 25,000 | — | $0 | 58,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-08-29 | 2022-08-31 | 4,073 | $66.14 | $269.4K | 311,206 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-08-29 | 2022-08-31 | 20,764 | $66.98 | $1.39M | 290,442 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-08-29 | 2022-08-31 | 163 | $67.64 | $11.0K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-08-29 | 2022-08-31 | 25,000 | $16.21 | $405.3K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-08-16 | 2022-08-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-08-16 | 2022-08-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-07-27 | 2022-07-29 | 16,667 | — | $0 | 83,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-07-27 | 2022-07-29 | 8,333 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-07-27 | 2022-07-29 | 8,333 | $12.57 | $104.7K | 298,612 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-07-27 | 2022-07-29 | 16,667 | $16.21 | $270.2K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 6,933 | $75.64 | $524.4K | 308,346 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 700 | $76.37 | $53.5K | 307,646 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 700 | $77.79 | $54.5K | 306,946 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 12,759 | $75.73 | $966.2K | 294,187 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 3,308 | $76.29 | $252.4K | 290,879 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-07-27 | 2022-07-29 | 600 | $77.97 | $46.8K | 290,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-06-30 | 2022-07-05 | 48,000 | — | $0 | 48,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-06-29 | 2022-07-01 | 25,000 | — | $0 | 8,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-06-29 | 2022-07-01 | 4,740 | $62.32 | $295.4K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-06-29 | 2022-07-01 | 25,000 | $12.57 | $314.3K | 315,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2022-06-29 | 2022-07-01 | 20,260 | $61.42 | $1.24M | 295,019 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2022-05-13 | 2022-05-16 | 49,000 | — | $0 | 49,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-03-14 | 2022-03-14 | 4,153 | $61.08 | $253.7K | 290,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-03-11 | 2022-03-14 | 9,000 | — | $0 | 27,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-03-11 | 2022-03-14 | 5,487 | $62.56 | $343.3K | 285,432 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-03-11 | 2022-03-14 | 9,000 | — | $0 | 294,432 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-03-10 | 2022-03-14 | 11,834 | — | $0 | 11,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-03-10 | 2022-03-14 | 11,834 | — | $0 | 290,919 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 53,000 | — | $0 | 53,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-12-20 | 2021-12-22 | 17,750 | — | $0 | 58,233 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-12-20 | 2021-12-22 | 17,750 | $1.81 | $32.1K | 279,085 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-12-06 | 2021-12-07 | 37,818 | $69.17 | $2.62M | 261,335 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-12-03 | 2021-12-07 | 80,000 | — | $0 | 40,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-12-03 | 2021-12-07 | 80,000 | — | $0 | 299,153 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-12-01 | 2021-12-03 | 779 | $75.10 | $58.5K | 219,153 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-10-15 | 2021-10-18 | 43,000 | — | $0 | 43,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-10-15 | 2021-10-18 | 33,000 | — | $0 | 75,983 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-10-15 | 2021-10-18 | 33,000 | $1.81 | $59.7K | 219,932 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-09-01 | 2021-09-03 | 787 | $124.83 | $98.2K | 186,932 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-08-05 | 2021-08-06 | 28,500 | — | $0 | 33,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-05 | 2021-08-06 | 4,700 | $127.82 | $600.8K | 210,519 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-05 | 2021-08-06 | 2,482 | $130.51 | $323.9K | 187,719 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-05 | 2021-08-06 | 6,819 | $129.82 | $885.2K | 190,201 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-05 | 2021-08-06 | 13,499 | $128.85 | $1.74M | 197,020 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-05 | 2021-08-06 | 1,000 | $126.67 | $126.7K | 215,219 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-08-05 | 2021-08-06 | 28,500 | $12.57 | $358.2K | 216,219 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-08-04 | 2021-08-06 | 1,500 | — | $0 | 61,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-08-04 | 2021-08-06 | 1,500 | $12.57 | $18.9K | 189,219 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-04 | 2021-08-06 | 1,500 | $125.02 | $187.5K | 187,719 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-06-15 | 2021-06-17 | 30,000 | — | $0 | 63,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-15 | 2021-06-17 | 3,488 | $127.51 | $444.8K | 187,719 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-15 | 2021-06-17 | 16,129 | $126.86 | $2.05M | 191,207 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-15 | 2021-06-17 | 10,383 | $125.39 | $1.30M | 207,336 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-06-15 | 2021-06-17 | 30,000 | $12.57 | $377.1K | 217,719 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-06-01 | 2021-06-03 | 779 | $115.80 | $90.2K | 187,719 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2021-05-13 | 2021-05-14 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-04-20 | 2021-04-23 | 14,921 | — | $0 | 14,921 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 36,000 | — | $0 | 36,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-10 | 2021-03-12 | 5,526 | $124.15 | $686.1K | 188,498 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-10 | 2021-03-12 | 11,833 | — | $0 | 194,024 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-01 | 2021-03-03 | 798 | $130.25 | $103.9K | 182,191 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-01-15 | 2021-01-20 | 20,000 | — | $0 | 108,983 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,304 | $217.44 | $283.5K | 182,989 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 3,140 | $211.83 | $665.1K | 199,849 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-01-15 | 2021-01-20 | 20,000 | $1.81 | $36.2K | 202,989 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 6,525 | $212.75 | $1.39M | 193,324 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,708 | $216.50 | $369.8K | 184,293 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,700 | $214.68 | $365.0K | 186,001 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 5,623 | $213.71 | $1.20M | 187,701 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-12-29 | 2020-12-30 | 13,800 | — | $0 | 128,983 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-12-29 | 2020-12-30 | 13,800 | $1.81 | $25.0K | 182,989 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-12-10 | 2020-12-11 | 20,000 | — | $0 | 142,783 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-10 | 2020-12-11 | 6,766 | $142.75 | $965.8K | 171,889 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-10 | 2020-12-11 | 5,500 | $141.17 | $776.4K | 183,689 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-12-10 | 2020-12-11 | 20,000 | $1.81 | $36.2K | 189,189 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-10 | 2020-12-11 | 600 | $144.97 | $87.0K | 169,189 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-10 | 2020-12-11 | 2,100 | $143.71 | $301.8K | 169,789 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-10 | 2020-12-11 | 5,034 | $141.98 | $714.7K | 178,655 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2020-12-01 | 2020-12-03 | 779 | $129.58 | $100.9K | 169,189 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-10-05 | 2020-10-06 | 47,333 | — | $0 | 47,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2020-09-02 | 2020-09-03 | 779 | $94.15 | $73.3K | 169,968 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2020-06-02 | 2020-06-03 | 779 | $66.26 | $51.6K | 170,747 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-06-01 | 2020-06-03 | 17,275 | — | $0 | 162,783 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-06-01 | 2020-06-03 | 17,275 | $1.81 | $31.3K | 188,801 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-01 | 2020-06-03 | 2,400 | $63.57 | $152.6K | 186,401 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-01 | 2020-06-03 | 9,300 | $64.61 | $600.9K | 177,101 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-01 | 2020-06-03 | 5,575 | $65.26 | $363.8K | 171,526 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-05-20 | 2020-05-21 | 10,693 | — | $0 | 180,058 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-20 | 2020-05-21 | 10,693 | $65.28 | $698.0K | 171,526 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-05-20 | 2020-05-21 | 10,693 | $1.81 | $19.4K | 182,219 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-05-19 | 2020-05-21 | 4,307 | — | $0 | 190,751 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-05-19 | 2020-05-21 | 4,307 | $1.81 | $7.8K | 175,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-19 | 2020-05-21 | 4,307 | $65.16 | $280.6K | 171,526 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 35,500 | — | $0 | 35,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 142,000 | — | $0 | 142,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2020-03-02 | 2020-03-04 | 794 | $52.74 | $41.9K | 171,526 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-12-16 | 2019-12-18 | 8,000 | — | $0 | 195,058 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-12-16 | 2019-12-18 | 8,000 | $1.81 | $14.5K | 172,320 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-12-03 | 2019-12-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2019-12-01 | 2019-12-02 | 741 | $71.65 | $53.1K | 164,320 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2019-09-01 | 2019-09-03 | 740 | $46.21 | $34.2K | 165,061 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-06-17 | 2019-06-19 | 20,000 | — | $0 | 203,058 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-06-17 | 2019-06-19 | 20,000 | $46.00 | $920.0K | 165,801 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-06-17 | 2019-06-19 | 20,000 | $1.81 | $36.2K | 185,801 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2019-06-01 | 2019-06-04 | 741 | $35.57 | $26.4K | 165,801 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-04-29 | 2019-05-01 | 20,000 | — | $0 | 223,058 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-04-29 | 2019-05-01 | 20,000 | $1.81 | $36.2K | 186,542 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-04-29 | 2019-05-01 | 20,000 | $42.03 | $840.6K | 166,542 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-03-05 | 2019-03-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2019-03-01 | 2019-03-05 | 748 | $39.97 | $29.9K | 166,542 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-12-07 | 2018-12-11 | 21,500 | — | $0 | 243,058 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-12-07 | 2018-12-11 | 21,500 | $1.81 | $38.9K | 167,290 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2018-12-01 | 2018-12-03 | 741 | $38.33 | $28.4K | 145,790 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2018-09-01 | 2018-09-04 | 741 | $56.67 | $42.0K | 146,531 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-15 | 109,000 | — | $0 | 109,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2018-06-04 | 2018-06-05 | 741 | $67.13 | $49.7K | 147,819 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-06-01 | 2018-06-05 | 15,000 | — | $0 | 264,558 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-06-01 | 2018-06-05 | 10,400 | $70.28 | $730.9K | 148,560 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-06-01 | 2018-06-05 | 4,600 | $67.28 | $309.5K | 158,960 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-06-01 | 2018-06-05 | 15,000 | $1.81 | $27.1K | 163,560 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-04-16 | 2018-04-18 | 75,000 | — | $0 | 150,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-03-07 | 2018-03-09 | 136,000 | — | $0 | 136,000 | SEC↗ |